The Healthcare industry has gained 4.1% in the last week and Hansoh Pharmaceutical Group up 7.8%. Meanwhile, WuXi Biologics (Cayman) actually underperformed within the industry, shrinking 17% in the last week. In the past year, the industry is down 34%. Looking forward, earnings are forecast to grow by 24% annually.
Has the Hong Kong Healthcare Sector valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 18 Mar 2024 | HK$1.4t | HK$1.4t | HK$27.8b | 11.7x | 49.3x | 1x |
Wed, 14 Feb 2024 | HK$1.3t | HK$1.4t | HK$25.8b | 11.4x | 48.6x | 0.9x |
Fri, 12 Jan 2024 | HK$1.5t | HK$1.4t | HK$26.0b | 12.3x | 57.5x | 1x |
Sun, 10 Dec 2023 | HK$1.5t | HK$1.4t | HK$26.3b | 12.3x | 58.9x | 1.1x |
Tue, 07 Nov 2023 | HK$1.7t | HK$1.4t | HK$25.1b | 13.5x | 67.6x | 1.2x |
Thu, 05 Oct 2023 | HK$1.6t | HK$1.4t | HK$24.6b | 12.1x | 64.9x | 1.1x |
Sat, 02 Sep 2023 | HK$1.6t | HK$1.4t | HK$27.3b | 11.7x | 58.4x | 1.1x |
Mon, 31 Jul 2023 | HK$1.7t | HK$1.4t | HK$14.2b | 14.2x | 122.7x | 1.3x |
Wed, 28 Jun 2023 | HK$1.7t | HK$1.3t | HK$3.0b | 14.4x | 555.8x | 1.2x |
Fri, 26 May 2023 | HK$1.8t | HK$1.4t | HK$3.2b | 14.8x | 549.8x | 1.3x |
Sun, 23 Apr 2023 | HK$1.9t | HK$1.4t | HK$3.9b | 15.1x | 501.8x | 1.4x |
Tue, 21 Mar 2023 | HK$1.8t | HK$1.3t | HK$1.7b | 15x | 1059.6x | 1.4x |
Thu, 16 Feb 2023 | HK$2.0t | HK$1.4t | HK$2.1b | 15.8x | 930.8x | 1.5x |
Sat, 14 Jan 2023 | HK$2.1t | HK$1.4t | HK$2.4b | 15.6x | 900.3x | 1.6x |
Mon, 12 Dec 2022 | HK$1.9t | HK$1.3t | HK$2.1b | 14x | 882x | 1.4x |
Wed, 09 Nov 2022 | HK$1.7t | HK$1.3t | HK$1.5b | 12.7x | 1109.7x | 1.3x |
Fri, 07 Oct 2022 | HK$1.5t | HK$1.3t | HK$3.0b | 13x | 505.6x | 1.2x |
Sun, 04 Sep 2022 | HK$1.7t | HK$1.3t | HK$3.6b | 14.6x | 475.3x | 1.3x |
Tue, 02 Aug 2022 | HK$1.8t | HK$1.3t | -HK$1,002,510,437.00 | 14.1x | -1781.8x | 1.4x |
Thu, 30 Jun 2022 | HK$1.9t | HK$1.3t | -HK$1,283,605,599.00 | 15.4x | -1477.2x | 1.4x |
Sat, 28 May 2022 | HK$1.6t | HK$1.3t | -HK$2,344,697,573.00 | 13.3x | -682.7x | 1.2x |
Mon, 25 Apr 2022 | HK$1.6t | HK$1.3t | -HK$2,457,860,259.00 | 13.4x | -662.8x | 1.2x |
Wed, 23 Mar 2022 | HK$1.8t | HK$1.4t | HK$7.0b | 13.3x | 260.3x | 1.3x |
Fri, 18 Feb 2022 | HK$2.0t | HK$1.3t | HK$7.9b | 14.3x | 253.9x | 1.5x |
Sun, 16 Jan 2022 | HK$2.3t | HK$1.3t | HK$7.9b | 15.6x | 293.7x | 1.7x |
Tue, 14 Dec 2021 | HK$2.4t | HK$1.3t | HK$8.0b | 14.2x | 304x | 1.8x |
Thu, 11 Nov 2021 | HK$2.5t | HK$1.3t | HK$8.0b | 14.9x | 318x | 1.9x |
Sat, 09 Oct 2021 | HK$2.7t | HK$1.3t | HK$7.8b | 15.4x | 338.6x | 2x |
Mon, 06 Sep 2021 | HK$3.0t | HK$1.3t | HK$7.8b | 17.5x | 383.1x | 2.3x |
Wed, 04 Aug 2021 | HK$3.3t | HK$1.3t | HK$7.5b | 17.8x | 438.7x | 2.6x |
Sat, 08 May 2021 | HK$3.8t | HK$1.2t | -HK$1,960,161,127.54 | 18.9x | -1918.2x | 3.1x |
81074.8x
Which industries have driven the changes within the Hong Kong Healthcare sector?
HK Market | 1.55% | |
Healthcare | 4.12% | |
Biotech | 8.34% | |
Pharma | 6.48% | |
Healthtech | 2.86% | |
Healthcare Services | 2.81% | |
Medical Equipment | 2.09% | |
Life Sciences | -9.62% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
3692 Hansoh Pharmaceutical Group | HK$15.16 | 7.8% +HK$6.5b | 11.1% | PE32.1x | |
1093 CSPC Pharmaceutical Group | HK$6.54 | 8.8% +HK$6.3b | -15.6% | PE11.7x | |
6990 Sichuan Kelun-Biotech Biopharmaceutical | HK$147.10 | 23.3% +HK$6.1b | n/a | PS19.7x | |
1177 Sino Biopharmaceutical | HK$3.27 | 9.7% +HK$5.3b | -23.2% | PE29.4x | |
2453 Concord Healthcare Group | HK$21.90 | 34.4% +HK$4.0b | n/a | PS23.5x |